Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series

BACKGROUND: Current systemic therapy for nontuberculous mycobacterial pulmonary infection is limited by poor clinical response rates, drug toxicities and side effects. The addition of aerosolized amikacin to standard oral therapy for nontuberculous mycobacterial pulmonary infection may improve treat...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Davis, Kala K, Kao, Peter N, Jacobs, Susan S, Ruoss, Stephen J
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2007
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1808062/
https://ncbi.nlm.nih.gov/pubmed/17319962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-7-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky